MARIA JULIANA ARBELAEZ LINERO: Open Payments
NPI 1407587041 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $323 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $65 |
| Ardelyx, Inc. | 4 | $61 |
| Exact Sciences Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: OTEZLA, IBSRELA, Cologuard Collection Kit, Wegovy, CAPLYTA, CONTRAVE, ZORYVE.
Industry payments across CT — which companies pay providers there.
